Gritstone bio to Participate in Upcoming Investor Conference
EMERYVILLE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq:GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor conference:
Related news for (GRTS)
- gritstone bio takes action to preserve value and strengthen capital structure
- gritstone bio takes action to preserve value and strengthen capital structure
- gritstone bio takes action to preserve value and strengthen capital structure
- gritstone bio takes action to preserve value and strengthen capital structure
- gritstone bio takes action to preserve value and strengthen capital structure
